(Q37905899)

25 August 2017

1 reference

title

Oestrogen receptors and signalling pathways: implications for neuroprotective effects of sex steroids in Parkinson's disease (English)

1 reference

25 August 2017

1 reference

1 reference

S Al Sweidi

1

1 reference

25 August 2017

M G Sánchez

2

1 reference

25 August 2017

M Bourque

3

1 reference

25 August 2017

M Morissette

4

1 reference

25 August 2017

D Dluzen

5

1 reference

25 August 2017

T Di Paolo

6

1 reference

25 August 2017

1 January 2012

1 reference

Journal of Neuroendocrinology

25 August 2017

1 reference

25 August 2017

24

1 reference

25 August 2017

1

1 reference

25 August 2017

48-61

1 reference

Parkinson's disease and parkinsonism in a longitudinal study: two-fold higher incidence in men. ILSA Working Group. Italian Longitudinal Study on Aging.

25 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976-1990.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Parkinsonism death rates by race, sex, and geography

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Risk of Parkinson's disease among first-degree relatives: A community-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Are men at greater risk for Parkinson's disease than women?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Gender differences in neurological disease: role of estrogens and cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Gender disparities in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Levodopa improves motor function without impairing cognition in mild non-demented Parkinson's disease patients. Parkinson Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Sex differences in clinical and genetic determinants of levodopa peak-dose dyskinesias in Parkinson disease: an exploratory study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Tamoxifen protects male mice nigrostriatal dopamine against methamphetamine-induced toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Steroids-dopamine interactions in the pathophysiology and treatment of CNS disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

alpha-Synuclein regulation of the dopaminergic transporter: a possible role in the pathogenesis of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

MPTP toxicity: implications for research in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

The parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a technical review of its utility and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Risk of Parkinson disease in women: effect of reproductive characteristics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Estrogens and Parkinson disease: neuroprotective, symptomatic, neither, or both?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Short-term effects of high-dose 17beta-estradiol in postmenopausal PD patients: a crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Estrogens and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Postmenopausal estrogen use affects risk for Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Cloning of a novel receptor expressed in rat prostate and ovary

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Estrogen receptor-beta potency-selective ligands: structure-activity relationship studies of diarylpropionitriles and their acetylene and polar analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Pyrazole ligands: structure-affinity/activity relationships and estrogen receptor-alpha-selective agonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Analysis of estrogen receptor expression in tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Steroid hormone receptors: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Comparative distribution of estrogen receptor-alpha and -beta mRNA in the rat central nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Immunolocalization of Estrogen Receptor β in the Mouse Brain: Comparison with Estrogen Receptor α

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Expression and neuropeptidergic characterization of estrogen receptors (ERalpha and ERbeta) throughout the rat brain: anatomical evidence of distinct roles of each subtype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Selective colocalization of immunoreactivity for intracellular gonadal hormone receptors and tyrosine hydroxylase in the ventral tegmental area, substantia nigra, and retrorubral fields in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Mesostriatal and mesolimbic projections of midbrain neurons immunoreactive for estrogen receptor beta or androgen receptors in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Expression of estrogen receptor-alpha and beta mRNA in the developing and adult mouse striatum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Estrogens and Parkinson disease: novel approach for neuroprotection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Gender difference in dopamine concentration and postischemic neuronal damage in neostriatum after unilateral dopamine depletion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Minireview: nuclear receptor coactivators--an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Transcription factor cross-talk: the estrogen receptor and NF-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

A novel, cell-type-specific mechanism for estrogen receptor-mediated gene activation in the absence of an estrogen-responsive element

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Estrogen modulation of the cyclic AMP response element-binding protein pathway. Effects of long-term and acute treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Genomic targets of nuclear estrogen receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Specific binding sites for oestrogen at the outer surfaces of isolated endometrial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Dual action of estrogen on glutamate-induced calcium signaling: mechanisms requiring interaction between estrogen receptors and src/mitogen activated protein kinase pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Estrogen and the brain: beyond ER-alpha, ER-beta, and 17beta-estradiol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Palmitoylation-dependent estrogen receptor alpha membrane localization: regulation by 17beta-estradiol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

A conserved mechanism for steroid receptor translocation to the plasma membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Nature of functional estrogen receptors at the plasma membrane.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Identification of a gene (GPR30) with homology to the G-protein-coupled receptor superfamily associated with estrogen receptor expression in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Cloning of a novel member of the G protein-coupled receptor family related to peptide receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

A novel putative G-protein-coupled receptor expressed in lung, heart and lymphoid tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Discovery of three novel G-protein-coupled receptor genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Cloning of human cDNA encoding a novel heptahelix receptor expressed in Burkitt's lymphoma and widely distributed in brain and peripheral tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Cloning of cDNAs encoding G protein-coupled receptor expressed in human endothelial cells exposed to fluid shear stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

G protein-coupled receptor 30 is an estrogen receptor in the plasma membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Distribution and characterization of estrogen receptor G protein-coupled receptor 30 in the rat central nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Expression and intracellular distribution of the G protein-coupled receptor 30 in rat hippocampal formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

A transmembrane intracellular estrogen receptor mediates rapid cell signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Mechanisms of estrogen signaling and gene expression via GPR30

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

GPR30 co-localizes with cholinergic neurons in the basal forebrain and enhances potassium-stimulated acetylcholine release in the hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Estrogen receptor immunoreactivity within subregions of the rat forebrain: neuronal distribution and association with perikarya containing choline acetyltransferase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Estrogen binding and estrogen receptor characterization (ERalpha and ERbeta) in the cholinergic neurons of the rat basal forebrain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Neuroendocrine influences and repercussions of the menopause

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

The aging process: where are the drug opportunities?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Age-dependent ERalpha MB1 splice variant expression in discrete areas of the human brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Estrogen receptor alpha and its splice variants in the hippocampus in aging and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Expression of estrogen receptor alpha exon-deleted mRNA variants in the human and non-human primate frontal cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

The naturally occurring variant of estrogen receptor (ER) ERDeltaE7 suppresses estrogen-dependent transcriptional activation by both wild-type ERalpha and ERbeta

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Potential age-dependent effects of estrogen on neural injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Protective actions of the vesicular monoamine transporter 2 (VMAT2) in monoaminergic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Regulation of dopamine transporter function by protein-protein interactions: new discoveries and methodological challenges.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Oestrogens prevent loss of dopamine transporter (DAT) and vesicular monoamine transporter (VMAT2) in substantia nigra of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Dendrite loss is a characteristic early indicator of toxin-induced neurodegeneration in rat midbrain slices.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

The effect of estrogen replacement on early Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Drugs with estrogen-like potency and brain activity: potential therapeutic application for the CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Modulation of brain dopamine transmission by sex steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Estrogenic properties of raloxifene, but not tamoxifen, on D2 and D3 dopamine receptors in the rat forebrain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Ovariectomy and estradiol treatment affect the dopamine transporter and its gene expression in the rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Sex and estrous cycle variations of rat striatal dopamine uptake sites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Effect of chronic estradiol and progesterone treatments of ovariectomized rats on brain dopamine uptake sites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

ERbeta mediates the estradiol increase of D2 receptors in rat striatum and nucleus accumbens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Chronic estradiol treatment increases anterior pituitary but not striatal D2 dopamine receptor mRNA levels in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Neuroprotective properties of 17beta-estradiol, progesterone, and raloxifene in MPTP C57Bl/6 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Influence of oestrogenic compounds on monoamine transporters in rat striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Regulation of rat brain vesicular monoamine transporter by chronic treatment with ovarian hormones.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Stereospecific prevention by 17beta-estradiol of MPTP-induced dopamine depletion in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Neuroprotective effects of estrogen upon the nigrostriatal dopaminergic system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

The Impact of Gender and Estrogen on Striatal Dopaminergic Neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Repeated estradiol treatment prevents MPTP-induced dopamine depletion in male mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Dehydroepiandrosterone (DHEA) such as 17beta-estradiol prevents MPTP-induced dopamine depletion in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Estrogen enhances the number of nigral dopaminergic neurons of adult male mice without affecting nigral neuroglial number and morphology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Neuroprotective actions of sex steroids in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Mechanisms of estrogen receptor signaling: convergence of genomic and nongenomic actions on target genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Neuroprotective effects of estrogens: potential mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Role of estrogen receptors in neuroprotection by estradiol against MPTP toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Differential modulation of estrogen receptors (ERs) in ischemic brain injury: a role for ERalpha in estradiol-mediated protection against delayed cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Neuroprotection by ovarian hormones in animal models of neurological disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Contribution of estrogen receptors alpha and beta to the effects of estradiol in the brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Implication of the phosphatidylinositol-3 kinase/protein kinase B signaling pathway in the neuroprotective effect of estradiol in the striatum of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Effect of estrogen receptor agonists treatment in MPTP mice: evidence of neuroprotection by an ER alpha agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Neuroprotective properties of selective estrogen receptor agonists in cultured neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Neuroprotection by a selective estrogen receptor beta agonist in a mouse model of global ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Association between the estrogen receptor beta gene and age of onset of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Estrogen receptors and gonadal steroids in vulnerability and protection of dopamine neurons in a mouse model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Estrogen receptor function as revealed by knockout studies: neuroendocrine and behavioral aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Estrogen Receptor Null Mice: What Have We Learned and Where Will They Lead Us?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Lung dysfunction causes systemic hypoxia in estrogen receptor beta knockout (ERbeta-/-) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Functional alterations of the nigrostriatal dopamine system in estrogen receptor-alpha knockout (ERKO) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Alternative estrogen receptors homologous to classical receptor alpha in murine neural tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Estrogen activates rapid signaling in the brain: role of estrogen receptor alpha and estrogen receptor beta in neurons and glia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Immunolocalisation of oestrogen receptor beta in human tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Estrogen receptor (ER)beta knockout mice reveal a role for ERbeta in migration of cortical neurons in the developing brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Estrogen receptor subtypes alpha and beta contribute to neuroprotection and increased Bcl-2 expression in primary hippocampal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Membrane estradiol signaling in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Virtual and biomolecular screening converge on a selective agonist for GPR30.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

In vivo effects of a GPR30 antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Sex differences in methamphetamine toxicity in mice: effect on brain dopamine signaling pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Effect of estradiol on striatal dopamine activity of female hemiparkinsonian monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

An Akt/beta-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

The Akt-GSK-3 signaling cascade in the actions of dopamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Akt/GSK3 signaling in the action of psychotropic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Association between AKT1 gene and Parkinson's disease: a protective haplotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

RTP801 is induced in Parkinson's disease and mediates neuron death by inhibiting Akt phosphorylation/activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Protective effects of estrogen and selective estrogen receptor modulators in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Estrogen activates classical and alternative mechanisms to orchestrate neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Integration of steroid hormone initiated membrane action to genomic function in the brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Insulin-like growth factor-I receptors and estrogen receptors interact in the promotion of neuronal survival and neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Plasma membrane oestrogen receptor mediates neuroprotection against beta-amyloid toxicity through activation of Raf-1/MEK/ERK cascade in septal-derived cholinergic SN56 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Estrogen receptor-mediated neuroprotection from oxidative stress requires activation of the mitogen-activated protein kinase pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Estrogen receptor alpha rapidly activates the IGF-1 receptor pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Estrogen receptor alpha forms estrogen-dependent multimolecular complexes with insulin-like growth factor receptor and phosphatidylinositol 3-kinase in the adult rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Interdependence of oestrogen and insulin-like growth factor-I in the brain: potential for analysing neuroprotective mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Striatal concentrations of vesicular monoamine transporters are identical in MPTP-sensitive (C57BL/6) and -insensitive (CD-1) mouse strains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

Striatal Akt/GSK3 signaling pathway in the development of L-Dopa-induced dyskinesias in MPTP monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2011.02193.X

10.1111/J.1365-2826.2011.02193.X

21 January 2018

Identifiers

DOI

1 reference

25 August 2017

1 reference